<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2015-1-23-28</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-494</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая трансплантология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical Transplantology</subject></subj-group></article-categories><title-group><article-title>ОЦЕНКА ПЕРФУЗИИ МИОКАРДА В ПРОГНОЗИРОВАНИИ ЭФФЕКТА КОРОНАРНОЙ АНГИОПЛАСТИКИ У ПАЦИЕНТОВ С ЗАСТОЙНОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ ИШЕМИЧЕСКОГО ГЕНЕЗА</article-title><trans-title-group xml:lang="en"><trans-title>MYOCARDIAL PERFUSION ASSESSMENT IN FORECASTING EFFECT OF CORONARY ANGIOPLASTY IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронков</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironkov</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">medax@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Честухин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chestukhin</surname><given-names>V. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бляхман</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Blyakhman</surname><given-names>F. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шкляр</surname><given-names>Т. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Shklyar</surname><given-names>T. F.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Остроумов</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostroumov</surname><given-names>E. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котина</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotina</surname><given-names>Е. D.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саховский</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakhovsky</surname><given-names>S. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Азоев</surname><given-names>Э. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Asoev</surname><given-names>E. T.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронков</surname><given-names>Б. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironkov</surname><given-names>B. L.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России, Москва, Российская Федерация&#13;
ГБОУ ВПО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России, Москва, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician V.I. Schumakov Federal Research Center of Transplantology&#13;
and Artificial Organs, Ministry of Health of the Russian Federation Moscow, Russian Federation&#13;
N.I. Pirogov Russian National Research Medical University, Moscow, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России, Москва, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician V.I. Schumakov Federal Research Center of Transplantology&#13;
and Artificial Organs, Ministry of Health of the Russian Federation Moscow, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБОУ ВПО «Уральский государственный медицинcкий университет» Минздрава России, Екатеринбург, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural State Medical University, Yekaterinburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБОУ «Санкт-Петербургский государственный университет», Санкт-Петербург, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State University of St. Petersburg, St. Petersburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>03</day><month>04</month><year>2015</year></pub-date><volume>17</volume><issue>1</issue><fpage>23</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Миронков А.Б., Честухин В.В., Бляхман Ф.А., Шкляр Т.Ф., Остроумов Е.Н., Котина Е.Д., Саховский С.А., Азоев Э.Т., Миронков Б.Л., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Миронков А.Б., Честухин В.В., Бляхман Ф.А., Шкляр Т.Ф., Остроумов Е.Н., Котина Е.Д., Саховский С.А., Азоев Э.Т., Миронков Б.Л.</copyright-holder><copyright-holder xml:lang="en">Mironkov A.B., Chestukhin V.V., Blyakhman F.A., Shklyar T.F., Ostroumov E.N., Kotina Е.D., Sakhovsky S.A., Asoev E.T., Mironkov B.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/494">https://journal.transpl.ru/vtio/article/view/494</self-uri><abstract><p>Цель. Определить влияние исходного нарушения перфузии левого желудочка (ЛЖ) на динамику клинического статуса больных с выраженной дисфункцией сердечной мышцы ишемической этиологии после коронарной ангиопластики. Материалы и методы. Обследовали 86 пациентов (81 мужчина и 5 женщин в возрасте от 46 до 73 лет) с диагнозом «ИБС, ХСН ФК 3–4 по NYHA». ЭхоКГ-параметры ЛЖ: фракция выброса менее 40%, конечный диастолический объем более 200 мл до и через 2–3 дня после чрескожного коронарного вмешательства. Нарушения перфузии оценивали с использованием однофотонной эмиссионной компьютерной томографии миокарда, синхронизированной с ЭКГ. В качестве категориальных предикторов служили: нарушения перфузии на верхушке ЛЖ (в баллах), нарушения перфузии в бассейнах ПМЖВ, ОВ и ПКА (%), общие нарушения перфузии ЛЖ (в баллах и %). Результаты. В 42% случаев 6-минутный тест увеличился до 3 раз; ФК NYHA уменьшился на 2 (группа 1). В 28 случаях 6-минутный тест увеличился до 2 раз и ФК NYHA снизился на 1. У 22 пациентов наблюдался прирост 6-минутного теста до 50% от исходных значений и отсутствовала динамика ФК по NYHA (из 50 пациентов второй группы). Исходная степень нарушения перфузии ЛЖ в целом в группе 1 – 41,2 ± 4,0%, в группе 2 – 58,3 ± 2,4 (р = 0,0004). Аналогичные значения получены для показателей перфузии в бассейне ПМЖВ и на верхушке ЛЖ. Нарушения перфузии миокарда в покое свидетельствуют о наличии кардиосклероза, а распространенность этих нарушений свидетельствует о распространенности кардиосклероза в сердечной мышце. Заключение. Степень нарушения перфузии миокарда ЛЖ у пациентов с выраженной сердечной недостаточностью ишемического генеза является ключевым показателем, влияющим на клиническую эффективность коронарной ангиопластики. Критической величиной для определения благоприятного прогноза реваскуляризации является 60% и более нарушение перфузии, свидетельствующее о том, что в сердечной мышце очаговый кардиосклероз преобладает над функционирующим миокардом. </p></abstract><trans-abstract xml:lang="en"><p>Aim. To define influence of the left ventricle (LV) perfusion defects on the clinical status dynamics after coronary angioplasty in patients with the expressed myocardium dysfunction of ischemic etiology. Materials and methods. Examined 86 patients (81 men and 5 women aged from 46 to 73 years) before and in 2–3 days after percutaneous coronary intervention with diagnosis: CAD, CHF with NYHA class III–IV, echocardiography parameters of LV: ejection fraction less than 40%, end-diastolic volume is more than 200 ml. Perfusion defects of myocardium estimated with use of ECG-gated single photon emission computed tomography. Predictors were defined: perfusion defects on LV apex (in score), perfusion defects in the area of LAD, LCx and RCA (%), the LV global perfusion defects (in score and %). Results. In 42% of cases 6-minute walk test increased to 3 times; The NYHA class decreased by 2 classes (group 1). In 28 cases 6-minute walk test increased to 2 times and the NYHA class decreased on 1 class. In 22 patients 6-minute walk test increased less than 50% of reference values and there was no dynamics NYHA class (50 patients of the group 2). Initial extent of LV global perfusion defects in group 1 – 41,2 ± 4,0%, in group 2 – 58,3 ± 2,4% (р = 0,0004). Similar values are received for perfusion indicators in the area of LAD and the LV apex. Prevalence of myocardial perfusion defects at rest reflects prevalence of a cardiosclerosis in a cardiac muscle. Conclusion. Degree of LV myocardial perfusion defects in patients with the expressed heart failure of ischemic etiology is the key indicator influencing clinical efficiency of coronary angioplasty. Critical size for definition of the favorable forecast of revascularization are 60% and more perfusion defects testifying that in a cardiac muscle the focal cardiosclerosis prevails over the functioning myocardium. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечная недостаточность</kwd><kwd>перфузия миокарда</kwd><kwd>чрескожное коронарное вмешательство</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure</kwd><kwd>myocardial perfusion</kwd><kwd>coronary angioplasty</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kunadian V, Pugh A, Zaman AG, Qiu W. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coron Artery Dis. 2012 Nov; 23 (7): 469–479.</mixed-citation><mixed-citation xml:lang="en">Kunadian V, Pugh A, Zaman AG, Qiu W. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coron Artery Dis. 2012 Nov; 23 (7): 469–479.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бокерия ЛА, Алекян БГ, Абросимов АВ, Айвазян ГГ. Чрескожные коронарные вмешательства у больных с дисфункцией левого желудочка (фракция выброса меньше или равна 30%). Грудная и сердечно-сосудистая хирургия. 2013; 6: 10–19. Bokeriya LA, Alekyan BG, Abrosimov AV, Ayvazyan GG. Chreskozhnye koronarnye vmeshatel'stva u bol'nyh s disfunkciey levogo zheludochka (frakciya vybrosa men'she ili ravna 30%). Grudnaya i serdechno-sosudistaya hirurgiya. 2013; 6: 10–19.</mixed-citation><mixed-citation xml:lang="en">Бокерия ЛА, Алекян БГ, Абросимов АВ, Айвазян ГГ. Чрескожные коронарные вмешательства у больных с дисфункцией левого желудочка (фракция выброса меньше или равна 30%). Грудная и сердечно-сосудистая хирургия. 2013; 6: 10–19. Bokeriya LA, Alekyan BG, Abrosimov AV, Ayvazyan GG. Chreskozhnye koronarnye vmeshatel'stva u bol'nyh s disfunkciey levogo zheludochka (frakciya vybrosa men'she ili ravna 30%). Grudnaya i serdechno-sosudistaya hirurgiya. 2013; 6: 10–19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шашкова НВ, Терещенко СН, Самойленко ЛЕ. Влияние ангиопластики на клиническое течение заболевания, перфузию и сократительную способность миокарда у больных с хронической сердечной недостаточностью ишемической этиологии. Кардиoлогия. 2014; 4 (54): 21–28. Shashkova NV, Tereshchenko SN, Samoylenko LE. Vliyanie angioplastiki na klinicheskoe techenie zabolevaniya, perfuziyu i sokratitel'nuyu sposobnost' miokarda u bol'nyh s hronicheskoy serdechnoy nedostatochnost'yu ishemicheskoy ehtiologii. Kardiologiya. 2014; 4 (54): 21–28.</mixed-citation><mixed-citation xml:lang="en">Шашкова НВ, Терещенко СН, Самойленко ЛЕ. Влияние ангиопластики на клиническое течение заболевания, перфузию и сократительную способность миокарда у больных с хронической сердечной недостаточностью ишемической этиологии. Кардиoлогия. 2014; 4 (54): 21–28. Shashkova NV, Tereshchenko SN, Samoylenko LE. Vliyanie angioplastiki na klinicheskoe techenie zabolevaniya, perfuziyu i sokratitel'nuyu sposobnost' miokarda u bol'nyh s hronicheskoy serdechnoy nedostatochnost'yu ishemicheskoy ehtiologii. Kardiologiya. 2014; 4 (54): 21–28.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Marui A, Kimura T, Nishiwaki N, Komiya T, Hanyu M, Shiomi H et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDOKyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†. Eur. J. Cardiothorac Surg. 2015 Feb; 47 (2): 316–321. doi: 10.1093/ejcts/ ezu131. Epub 2014 Mar 23.</mixed-citation><mixed-citation xml:lang="en">Marui A, Kimura T, Nishiwaki N, Komiya T, Hanyu M, Shiomi H et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDOKyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†. Eur. J. Cardiothorac Surg. 2015 Feb; 47 (2): 316–321. doi: 10.1093/ejcts/ ezu131. Epub 2014 Mar 23.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Buszman P, Szkróbka I, Tendera Z, Gruszka1 A, Bialkowska B, Parma R et al. Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry). EuroInterv. 2005; 1: 186–192.</mixed-citation><mixed-citation xml:lang="en">Buszman P, Szkróbka I, Tendera Z, Gruszka1 A, Bialkowska B, Parma R et al. Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry). EuroInterv. 2005; 1: 186–192.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Программа обработки кардиологических функциональных исследований (ИНДИС-КАРФИ). Свидетельство о госрегистрации программы для ЭВМ No 2014662434, 28.11.2014 г. Programma obrabotki kardiologicheskih funkcional'nyh issledovaniy (INDIS-KARFI). Svidetel'stvo o gosregistracii programmy dlya EHVM No 2014662434, 28.11.2014 g.</mixed-citation><mixed-citation xml:lang="en">Программа обработки кардиологических функциональных исследований (ИНДИС-КАРФИ). Свидетельство о госрегистрации программы для ЭВМ No 2014662434, 28.11.2014 г. Programma obrabotki kardiologicheskih funkcional'nyh issledovaniy (INDIS-KARFI). Svidetel'stvo o gosregistracii programmy dlya EHVM No 2014662434, 28.11.2014 g.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gould KL. Focus for the new millennium – diffuse coronary artery disease and new paradigms in cardiovascular medicine. ACC Curr. J. Review. 2000; 9: 10–16.</mixed-citation><mixed-citation xml:lang="en">Gould KL. Focus for the new millennium – diffuse coronary artery disease and new paradigms in cardiovascular medicine. ACC Curr. J. Review. 2000; 9: 10–16.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber BL, Rousseau MF, Ahn SA, le Polain de Waroux JB, Pouleur AC, Phlips T et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. Am. Coll. Cardiol. 2012 Feb 28; 59 (9): 825–835. doi: 10.1016/j.jacc.2011.09.073</mixed-citation><mixed-citation xml:lang="en">Gerber BL, Rousseau MF, Ahn SA, le Polain de Waroux JB, Pouleur AC, Phlips T et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. Am. Coll. Cardiol. 2012 Feb 28; 59 (9): 825–835. doi: 10.1016/j.jacc.2011.09.073</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzello V, Schinkel AF, Bax JJ et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scarto-biphasic model. Am. J. Cardiol. 2003 Jun 15; 91 (12): 1406–1409.</mixed-citation><mixed-citation xml:lang="en">Rizzello V, Schinkel AF, Bax JJ et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scarto-biphasic model. Am. J. Cardiol. 2003 Jun 15; 91 (12): 1406–1409.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Schinkel AF, Valkema R, Geleijnse ML, Sijbrands EJ, Poldermans D. Single-photon emission computed tomography for assessment of myocardial viability. EuroIntervention. 2010 May; 6 Suppl G: 115–122. doi: 10.4244/.</mixed-citation><mixed-citation xml:lang="en">Schinkel AF, Valkema R, Geleijnse ML, Sijbrands EJ, Poldermans D. Single-photon emission computed tomography for assessment of myocardial viability. EuroIntervention. 2010 May; 6 Suppl G: 115–122. doi: 10.4244/.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Samady H, Elefteriades JA, Abbott BG et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999; 100: 1298–304.</mixed-citation><mixed-citation xml:lang="en">Samady H, Elefteriades JA, Abbott BG et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999; 100: 1298–304.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
